Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the Department for Education on (a) the impact of university debt on nursing degree graduates and (b) a student loan forgiveness model for those graduates.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care works closely with the Department for Education on a wide range of matters to ensure the education system is supporting healthcare students, while delivering value for money for taxpayers. Student funding arrangements are reviewed annually ahead of the start of each academic year. The Government currently has no plans to introduce a student loan forgiveness model for nursing degree graduates.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to paragraph 2.40 of the Autumn Budget 2024, published on 30 October, whether he has made an estimate of the overall cost to GP practices of the proposed increase to employer National Insurance contributions.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We have taken necessary decisions to fix the foundations in the public finances at the Autumn Budget 2024, which enabled the Spending Review settlement of a £22.6 billion increase in resource spending for the Department from 2023/24 outturn to 2025/26. The employer National Insurance rise will be implemented in April 2025, and the Department will set out further details on the allocation of funding for next year at the earliest opportunity.
Primary care providers, including general practice, dentistry, pharmacy, and eye care, are valued independent contractors who provide nearly £20 billion worth of services in the National Health Service. Every year we consult with each sector both about what services they provide, and the money providers are entitled to in return under their contract. As in previous years, this issue will be dealt with as part of that process.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will hold discussions with the National Institute for Health and Care Excellence on the potential merits of considering the potential impact of new treatments on caregivers when determining the cost-effectiveness of those treatments.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We have no plans to hold such discussions. The National Institute for Health and Care Excellence (NICE) develops its guidance independently and in line with its established methods and processes, which have been developed through extensive engagement with interested parties to ensure that they reflect best practice and societal preferences.
In its evaluations of new medicines, the NICE considers National Health Service and publicly funded personal social services (PSS) costs and, when relevant, the health impact of treatments on carers. Any changes to the NICE’s methods to include a wider economic perspective to, for example, account for productivity benefits to carers, would be methodologically and ethically challenging and could have unintended consequences. There is a risk that such a change could result in fewer treatments being recommended for populations that are disproportionately older, economically inactive, or have greater care needs. It is crucial that the NICE’s methods remain fair, consistent, and provide the most health benefit for society.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with (a) NHS England, (b) the National Institute for Health and Care Excellence and (c) the Medicines and Healthcare products Regulatory Agency on access for patients to licensed treatments for Alzheimer's disease.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Ministers have had a number of recent discussions with the Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE), and NHS England, about patient access to new, licensed treatments for Alzheimer’s disease.
Recommendations on whether new licensed medicines should be routinely funded by the National Health Service are made independently by the NICE on the basis of an assessment of their costs and benefits. The methods and processes that the NICE uses are internationally respected and have been developed through extensive engagement with academics, industry, patients, and clinicians, to ensure that they reflect best practice and societal preferences. The NHS in England is legally required to fund medicines recommended in a NICE appraisal, usually within three months of final guidance.
The Dame Barbara Windsor Dementia Goals programme aims to speed up the development of new treatments for dementia and neurodegenerative conditions, and is working with the relevant partners to develop solutions around access for patients to licensed treatments for Alzheimer’s disease.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many Integrated Care Systems do not have an open Women's Health Hub.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department has invested £25 million over 2023/24 and 2024/25 to support the establishment of at least one pilot women’s health hub in every integrated care system. The National Health Services’ Priorities and operational planning guidance 2024/25 asks integrated care boards (ICBs) to establish and develop at least one women’s health hub in every ICB by December 2024, working in partnership with local authorities.
NHS England has asked the ICBs to report regularly on their progress in implementing the funding. As of September 2024, six of the 42 ICBs had not provided a recent update or had reported to NHS England that their women’s health hub was not yet open.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of increasing funding for children’s hospices in line with (a) inflationary pressures and (b) operational costs in future financial years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We want a society where every person receives high-quality, compassionate care from diagnosis through to the end of life. Palliative care services are included in the list of services an integrated care board (ICB) must commission. NHS England has published statutory guidance and service specifications to support ICBs in this duty.
2023/24 was the final year of the Children’s Hospice Grant. In 2024/25, however, NHS England provided an additional £25 million of funding for children and young people’s hospices, maintaining the level of grant funding from 2023/24. This funding was distributed, for the first time, via ICBs, in line with National Health Service devolution.
We understand that, financially, times are difficult for many voluntary and charitable organisations, including children’s hospices, due to the increased cost of living. We want a society where these costs are manageable for both voluntary organisations, like hospices, and the people whom they serve.
I recently met NHS England, Together for Short Lives, and one of the chairs of the Children Who Need Palliative Care All Party Parliamentary Group to discuss children’s palliative and end of life care, and this funding stream was discussed at length at that meeting. NHS England is currently considering the future of this important funding stream beyond 2024/25.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the removal of funding for children’s hospices.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We want a society where every person receives high-quality, compassionate care from diagnosis through to the end of life. Palliative care services are included in the list of services an integrated care board (ICB) must commission. NHS England has published statutory guidance and service specifications to support ICBs in this duty.
2023/24 was the final year of the Children’s Hospice Grant. In 2024/25, however, NHS England provided an additional £25 million of funding for children and young people’s hospices, maintaining the level of grant funding from 2023/24. This funding was distributed, for the first time, via ICBs, in line with National Health Service devolution.
We understand that, financially, times are difficult for many voluntary and charitable organisations, including children’s hospices, due to the increased cost of living. We want a society where these costs are manageable for both voluntary organisations, like hospices, and the people whom they serve.
I recently met NHS England, Together for Short Lives, and one of the chairs of the Children Who Need Palliative Care All Party Parliamentary Group to discuss children’s palliative and end of life care, and this funding stream was discussed at length at that meeting. NHS England is currently considering the future of this important funding stream beyond 2024/25.